The Effects of Immunotherapy in the Nose (Birch11)
The Molecular Biological Effects of Immunotherapy in the Nose
Sponsor: Finnish Institute of Occupational Health
A NA clinical study on Rhinitis, Allergic, Seasonal, this trial is completed. The trial is conducted by Finnish Institute of Occupational Health and has accumulated 11 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Sep 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jun 2021 — Sep 2021 [monthly]
Completed NA
-
May 2021 — Jun 2021 [monthly]
Completed NA
-
Jan 2021 — May 2021 [monthly]
Completed NA
-
Apr 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Apr 2020 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Finnish Institute of Occupational Health
- Helsinki University Central Hospital
- University of Helsinki
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.